KIMS - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 3.2

📈 Optimal Trade Setup

• Buy Price: ₹715–₹719 (if price sustains above ₹715 with volume confirmation).
• Profit Exit Level: ₹730–₹735 (near 50 DMA resistance).
• Stop-Loss: ₹705 (below recent support and psychological level).

📊 If Already Holding

• Exit Signal: RSI at 47.2 is neutral, MACD at -0.15 is flat — exit if price fails to hold ₹715 intraday.
• Volume: Current volume (3.38L) is above 1-week average (1.98L) — rising intraday interest.
• Exit Point: Consider exiting near ₹730–₹735 unless MACD turns positive and RSI crosses 50 intraday.

✅ Positive

• Price above 200 DMA (₹672) — long-term support intact.
• Volume surge suggests growing intraday interest.
• Strong fundamentals: ROCE 16.0%, ROE 14.0%, EPS ₹7.52.
• DII holding increased by 0.47% — improving domestic sentiment.
• Low debt-to-equity ratio of 0.33 — healthy balance sheet.

⚠️ Limitation

• MACD slightly negative and RSI below 50 — weak momentum.
• Price below 50 DMA (₹723) — short-term resistance overhead.
• High P/E of 98.4 and extreme PEG ratio of 328 — valuation concerns.
• FII holding declined by 0.51% — cautious foreign sentiment.
• Quarterly PAT dropped from ₹85.1 Cr. to ₹58.8 Cr. — 3.13% decline.

📰 Company Negative News

• Recent earnings contraction and high valuation metrics suggest short-term caution.

📢 Company Positive News

• Strong institutional interest from DIIs and technical support above 200 DMA support intraday stability.

🏗️ Industry

• Industry PE at 57.2 — KIMS trades at a premium (PE 98.4), reflecting high growth expectations.
• Healthcare sector supported by rising demand for specialty care and hospital expansion.

🧾 Conclusion

• KIMS is a moderately favorable intraday candidate today with rising volume and long-term support, but weak momentum and valuation risks warrant caution.
• Entry near ₹719 is viable if volume sustains; exit near ₹735 for short-term gains.
• If already holding, monitor MACD and RSI for continuation or reversal signals intraday.

I can also compare KIMS’s setup with peers like Apollo Hospitals or Narayana Health to help you identify stronger intraday momentum opportunities.